image
Healthcare - Biotechnology - NASDAQ - CH
$ 48.83
-6.99 %
$ 3.08 B
Market Cap
-38.45
P/E
BALANCE SHEET
527 M ASSETS
585.21%
13 M LIABILITIES
61.57%
496 M EQUITY
913.69%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition MoonLake Immunotherapeutics
image
Current Assets 514 M
Cash & Short-Term Investments 511 M
Receivables 1.06 M
Other Current Assets 2.1 M
Non-Current Assets 12.4 M
Long-Term Investments 0
PP&E 3.95 M
Other Non-Current Assets 8.42 M
Current Liabilities 9.97 M
Accounts Payable 265 K
Short-Term Debt 1.31 M
Other Current Liabilities 8.4 M
Non-Current Liabilities 3.08 M
Long-Term Debt 2.5 M
Other Non-Current Liabilities 583 K

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020
ASSETS
Cash & Cash Equivalents 451.2 39.5 8.0 1.3
Short Term Investments 59.8 32.6 0 0
Receivables 1.1 0.2 0.1 0
Inventory 0 0 1.3 0
Other Current Assets 2.1 4.2 1.4 0.3
Total Current Assets 514.2 76.5 9.6 1.6
PP&E 3.9 0.3 45.7 K 0
Intangible Assets 0 0 0 0
Goodwill 0 0 0 0
Long Term Investments 0 0 115.0 115.0
Other Long Term Assets 8.4 0 (115.0) 0
Other Assets 0 0 0 0
Total Assets 526.5 76.8 9.7 116.6
LIABILITIES
Accounts Payable 0.3 47.5 K 1.2 0
Short Term Debt 1.3 0.2 15.0 58.1 K
Other Current Liabilities 8.0 7.4 4.8 67.1 K
Total Current Liabilities 10.0 7.7 21.1 0.1
Long Term Debt 2.5 0.1 0 0
Deferred Tax Income 0 0 0 0
Other Liabilities 0.6 0.3 0.2 4.0
Total Liabilities 13.0 8.1 21.3 4.2
EQUITY
Common Stock 6.3 K 5.27 K 38.5 K 115.0
Retained Earnings (116.7) (80.7) (53.6) (2.5)
Other Accumulative Comprehensive Income/Loss 2.4 0.4 (0.2) 0
Total Equity 513.5 68.8 (11.6) 112.5
Total Liabilities and Equity 526.5 76.8 9.7 116.6
SHARES OUTSTANDING
Common Shares Outstanding 49.1 29.4 7.8 14.8